Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!

发布文献求助

ph

Lv7

4538 积分 2021-02-13 加入

最近求助
最近应助
互助留言

Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System ( FAERS ) Database: A Real‐World Pharmacovigilance Study 4天前 已完结
Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System ( FAERS ) Database: A Real‐World Pharmacovigilance Study 4天前 已完结
Virus‐triggered secondary hemophagocytic lymphohistiocytosis 12天前 已完结
Dynamic reprogramming of the tumor immune network via multicycle checkpoint degradation for cancer immunotherapy 13天前 已完结
Revised criteria for the diagnosis and staging of Alzheimer’s disease 1个月前 已完结
Robust deep learning based protein sequence design using ProteinMPNN 1个月前 已完结
Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy 2个月前 已完结
Controllable multivalent LYTACs enhance targeted protein degradation 2个月前 已完结
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis 2个月前 已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier 2个月前 已完结

没有进行任何应助

內容错误 5个月前
錯誤doi【积分已退回】 7个月前

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：821889395【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通